Sorry, you need to enable JavaScript to visit this website.
Organisation

Ministry of Health (New Zealand)

Owning Institution:
Alternate Name:

Manatū Hauora

Report

Health and independence report 2023


The 2023 health and independence report provides a comprehensive overview of the state of public health in Aotearoa New Zealand for the 2023 calendar year. To do so, it combines up-to-date information on a range of measures that illustrate key trends and other factors affecting the health and wellbeing of New Zealanders.
Discussion paper

Strategy to prevent and minimise gambling harm 2025/26 to 2027/28: consultation document


The Gambling Act 2003 (the Act) sets out requirements for an ‘integrated problem gambling strategy focused on public health’. This consultation paper seeks comment on the proposed direction and content of a draft Strategy on mental health and addiction and includes: the problem definition and needs assessment; the strategic plan; the service plan including the...
Report

Independent review of disability support services: phase one report


This report provides advice from an independent panel of reviewers on the immediate steps needed to be taken to better manage increasing money pressures faced by the recently established New Zealand Ministry of Disabled People - Whaikaha.
Strategy

Aotearoa New Zealand Rare Disorders Strategy


This Strategy provides a framework and long-term priorities that will guide health entities in improving health and wellbeing outcomes for people with rare disorders over the next decade, improving system responsiveness and support for people living with rare disorders as well as for service providers.
Strategy

New Zealand pandemic plan: a framework for action


This document outlines the all-of-government measures to be taken to prepare for and respond to a pandemic in New Zealand. The interim update was completed at pace, is limited in scope, and reflects changes to how the health system is run since the 2022 reforms and some of the early lessons from the COVID-19 response.